IIT Ropar Develops Alternative To Alcohol-Based Disinfectant

Chandigarh : The IIT Ropar on Tuesday said it has developed a low-cost device to produce electrolysed water that could be used as an alternative to alcohol-based disinfectant.

A team of Dr. Vishwajeet Mehandia, assistant professor, Dr.S. Manigandan of the Department of Chemical Engineering, and Prof. C.R. Suri, head, central research facility, has developed the device. An official statement said the electrolysed water could be used to combat COVID-19.

The acidic electrolysed water has a pH of 5.0-6.5 and high concentration of Free Available Chlorine (FAC). It was reported recently that freely available chlorine can potently inactivate the virus. The electrolysed water also shows strong killing activity against bacteria, fungi and many other types of viruses, said the statement.

Unlike traditional procedure of cleaning water with chlorine treatment, electrolysed water does not harm humans. It also shows strong activity against food-borne pathogens that could be beneficial for food and agricultural industries, it said.

“We have successfully developed the electrolysed water from the tap water in our laboratory with a pH of 5.0-6.5 and a high concentration of FAC. It can be prepared within five minutes and is stable up to one week. We have tested the stability of electrolysed water for up to 48 hours,” said Dr. Mehandia.

Prof. Suri said, “It can be used in healthcare, food safety, water treatment, and general sanitation.”

Dr. Manigandan said the electrolysed water can be used as “a powerful natural tool” in the fight against the COVID-19 virus. It is non-toxic and non-flammable and therefore does not require hazardous or chemical storage or handling precautions. Nor are there any special shipping or export requirements.”

The team is also in touch with a few industrial partners to commercialise the technology, he said.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework